Table of Content

1 Gabapentin Enacarbil Market Overview
1.1 Product Overview and Scope of Gabapentin Enacarbil
1.2 Gabapentin Enacarbil Segment by Type
1.2.1 Global Gabapentin Enacarbil Market Value Comparison by Type (2024-2034)
1.2.2 Capsule
1.2.3 Tablet
1.3 Gabapentin Enacarbil Segment by Application
1.3.1 Global Gabapentin Enacarbil Market Value by Application: (2024-2034)
1.3.2 Post-Herpetic Neuralgia (PHN)
1.3.3 Restless Legs Syndrome (RLS)
1.3.4 Others
1.4 Global Gabapentin Enacarbil Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Enacarbil Revenue 2018-2034
1.4.2 Global Gabapentin Enacarbil Sales 2018-2034
1.4.3 Global Gabapentin Enacarbil Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Gabapentin Enacarbil Market Competition by Manufacturers
2.1 Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2018-2024)
2.2 Global Gabapentin Enacarbil Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Gabapentin Enacarbil Average Price by Manufacturers (2018-2024)
2.4 Global Gabapentin Enacarbil Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Gabapentin Enacarbil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin Enacarbil, Product Type & Application
2.7 Gabapentin Enacarbil Market Competitive Situation and Trends
2.7.1 Gabapentin Enacarbil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gabapentin Enacarbil Players Market Share by Revenue
2.7.3 Global Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Enacarbil Retrospective Market Scenario by Region
3.1 Global Gabapentin Enacarbil Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Gabapentin Enacarbil Global Gabapentin Enacarbil Sales by Region: 2018-2034
3.2.1 Global Gabapentin Enacarbil Sales by Region: 2018-2024
3.2.2 Global Gabapentin Enacarbil Sales by Region: 2024-2034
3.3 Global Gabapentin Enacarbil Global Gabapentin Enacarbil Revenue by Region: 2018-2034
3.3.1 Global Gabapentin Enacarbil Revenue by Region: 2018-2024
3.3.2 Global Gabapentin Enacarbil Revenue by Region: 2024-2034
3.4 North America Gabapentin Enacarbil Market Facts & Figures by Country
3.4.1 North America Gabapentin Enacarbil Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Gabapentin Enacarbil Sales by Country (2018-2034)
3.4.3 North America Gabapentin Enacarbil Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gabapentin Enacarbil Market Facts & Figures by Country
3.5.1 Europe Gabapentin Enacarbil Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Gabapentin Enacarbil Sales by Country (2018-2034)
3.5.3 Europe Gabapentin Enacarbil Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Enacarbil Market Facts & Figures by Country
3.6.1 Asia Pacific Gabapentin Enacarbil Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Gabapentin Enacarbil Sales by Country (2018-2034)
3.6.3 Asia Pacific Gabapentin Enacarbil Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gabapentin Enacarbil Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Enacarbil Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Gabapentin Enacarbil Sales by Country (2018-2034)
3.7.3 Latin America Gabapentin Enacarbil Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Enacarbil Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Enacarbil Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Gabapentin Enacarbil Sales by Country (2018-2034)
3.8.3 Middle East and Africa Gabapentin Enacarbil Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gabapentin Enacarbil Sales by Type (2018-2034)
4.1.1 Global Gabapentin Enacarbil Sales by Type (2018-2024)
4.1.2 Global Gabapentin Enacarbil Sales by Type (2024-2034)
4.1.3 Global Gabapentin Enacarbil Sales Market Share by Type (2018-2034)
4.2 Global Gabapentin Enacarbil Revenue by Type (2018-2034)
4.2.1 Global Gabapentin Enacarbil Revenue by Type (2018-2024)
4.2.2 Global Gabapentin Enacarbil Revenue by Type (2024-2034)
4.2.3 Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2034)
4.3 Global Gabapentin Enacarbil Price by Type (2018-2034)
5 Segment by Application
5.1 Global Gabapentin Enacarbil Sales by Application (2018-2034)
5.1.1 Global Gabapentin Enacarbil Sales by Application (2018-2024)
5.1.2 Global Gabapentin Enacarbil Sales by Application (2024-2034)
5.1.3 Global Gabapentin Enacarbil Sales Market Share by Application (2018-2034)
5.2 Global Gabapentin Enacarbil Revenue by Application (2018-2034)
5.2.1 Global Gabapentin Enacarbil Revenue by Application (2018-2024)
5.2.2 Global Gabapentin Enacarbil Revenue by Application (2024-2034)
5.2.3 Global Gabapentin Enacarbil Revenue Market Share by Application (2018-2034)
5.3 Global Gabapentin Enacarbil Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Arbor Pharma
6.1.1 Arbor Pharma Corporation Information
6.1.2 Arbor Pharma Description and Business Overview
6.1.3 Arbor Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Arbor Pharma Gabapentin Enacarbil Product Portfolio
6.1.5 Arbor Pharma Recent Developments/Updates
6.2 Astellas
6.2.1 Astellas Corporation Information
6.2.2 Astellas Description and Business Overview
6.2.3 Astellas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Astellas Gabapentin Enacarbil Product Portfolio
6.2.5 Astellas Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GlaxoSmithKline Gabapentin Enacarbil Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Glenmark Pharma
6.4.1 Glenmark Pharma Corporation Information
6.4.2 Glenmark Pharma Description and Business Overview
6.4.3 Glenmark Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Glenmark Pharma Gabapentin Enacarbil Product Portfolio
6.4.5 Glenmark Pharma Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Pfizer Gabapentin Enacarbil Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Depomed
6.6.1 Depomed Corporation Information
6.6.2 Depomed Description and Business Overview
6.6.3 Depomed Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Depomed Gabapentin Enacarbil Product Portfolio
6.6.5 Depomed Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Teva Gabapentin Enacarbil Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Mylan Gabapentin Enacarbil Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Novartis Gabapentin Enacarbil Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Apotex
6.10.1 Apotex Corporation Information
6.10.2 Apotex Description and Business Overview
6.10.3 Apotex Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Apotex Gabapentin Enacarbil Product Portfolio
6.10.5 Apotex Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Gabapentin Enacarbil Description and Business Overview
6.11.3 Sun Pharmaceutical Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Sun Pharmaceutical Gabapentin Enacarbil Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Gabapentin Enacarbil Description and Business Overview
6.12.3 Aurobindo Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Aurobindo Pharma Gabapentin Enacarbil Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Intas
6.13.1 Intas Corporation Information
6.13.2 Intas Gabapentin Enacarbil Description and Business Overview
6.13.3 Intas Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Intas Gabapentin Enacarbil Product Portfolio
6.13.5 Intas Recent Developments/Updates
6.14 Amneal
6.14.1 Amneal Corporation Information
6.14.2 Amneal Gabapentin Enacarbil Description and Business Overview
6.14.3 Amneal Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Amneal Gabapentin Enacarbil Product Portfolio
6.14.5 Amneal Recent Developments/Updates
6.15 Marksans Pharma
6.15.1 Marksans Pharma Corporation Information
6.15.2 Marksans Pharma Gabapentin Enacarbil Description and Business Overview
6.15.3 Marksans Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Marksans Pharma Gabapentin Enacarbil Product Portfolio
6.15.5 Marksans Pharma Recent Developments/Updates
6.16 Alkem
6.16.1 Alkem Corporation Information
6.16.2 Alkem Gabapentin Enacarbil Description and Business Overview
6.16.3 Alkem Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Alkem Gabapentin Enacarbil Product Portfolio
6.16.5 Alkem Recent Developments/Updates
6.17 Jiangsu Enhua
6.17.1 Jiangsu Enhua Corporation Information
6.17.2 Jiangsu Enhua Gabapentin Enacarbil Description and Business Overview
6.17.3 Jiangsu Enhua Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Jiangsu Enhua Gabapentin Enacarbil Product Portfolio
6.17.5 Jiangsu Enhua Recent Developments/Updates
6.18 Jiangsu Hengrui
6.18.1 Jiangsu Hengrui Corporation Information
6.18.2 Jiangsu Hengrui Gabapentin Enacarbil Description and Business Overview
6.18.3 Jiangsu Hengrui Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Jiangsu Hengrui Gabapentin Enacarbil Product Portfolio
6.18.5 Jiangsu Hengrui Recent Developments/Updates
6.19 Sailike Pharma
6.19.1 Sailike Pharma Corporation Information
6.19.2 Sailike Pharma Gabapentin Enacarbil Description and Business Overview
6.19.3 Sailike Pharma Gabapentin Enacarbil Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Sailike Pharma Gabapentin Enacarbil Product Portfolio
6.19.5 Sailike Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Enacarbil Industry Chain Analysis
7.2 Gabapentin Enacarbil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Enacarbil Production Mode & Process
7.4 Gabapentin Enacarbil Sales and Marketing
7.4.1 Gabapentin Enacarbil Sales Channels
7.4.2 Gabapentin Enacarbil Distributors
7.5 Gabapentin Enacarbil Customers
8 Gabapentin Enacarbil Market Dynamics
8.1 Gabapentin Enacarbil Industry Trends
8.2 Gabapentin Enacarbil Market Drivers
8.3 Gabapentin Enacarbil Market Challenges
8.4 Gabapentin Enacarbil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Gabapentin Enacarbil Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Gabapentin Enacarbil Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Gabapentin Enacarbil Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gabapentin Enacarbil Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Gabapentin Enacarbil Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Gabapentin Enacarbil Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Gabapentin Enacarbil Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Gabapentin Enacarbil Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Gabapentin Enacarbil, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Gabapentin Enacarbil, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabapentin Enacarbil, Product Type & Application
Table 12. Global Key Manufacturers of Gabapentin Enacarbil, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabapentin Enacarbil by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Enacarbil as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabapentin Enacarbil Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Gabapentin Enacarbil Sales by Region (2018-2024) & (K Units)
Table 18. Global Gabapentin Enacarbil Sales Market Share by Region (2018-2024)
Table 19. Global Gabapentin Enacarbil Sales by Region (2024-2034) & (K Units)
Table 20. Global Gabapentin Enacarbil Sales Market Share by Region (2024-2034)
Table 21. Global Gabapentin Enacarbil Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Gabapentin Enacarbil Revenue Market Share by Region (2018-2024)
Table 23. Global Gabapentin Enacarbil Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Gabapentin Enacarbil Revenue Market Share by Region (2024-2034)
Table 25. North America Gabapentin Enacarbil Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Gabapentin Enacarbil Sales by Country (2018-2024) & (K Units)
Table 27. North America Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 28. North America Gabapentin Enacarbil Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Gabapentin Enacarbil Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Gabapentin Enacarbil Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Gabapentin Enacarbil Sales by Country (2018-2024) & (K Units)
Table 32. Europe Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 33. Europe Gabapentin Enacarbil Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Gabapentin Enacarbil Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Gabapentin Enacarbil Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Gabapentin Enacarbil Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Gabapentin Enacarbil Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Gabapentin Enacarbil Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Gabapentin Enacarbil Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Gabapentin Enacarbil Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Gabapentin Enacarbil Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Gabapentin Enacarbil Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Gabapentin Enacarbil Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Gabapentin Enacarbil Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Gabapentin Enacarbil Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Gabapentin Enacarbil Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Gabapentin Enacarbil Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Gabapentin Enacarbil Sales (K Units) by Type (2018-2024)
Table 51. Global Gabapentin Enacarbil Sales (K Units) by Type (2024-2034)
Table 52. Global Gabapentin Enacarbil Sales Market Share by Type (2018-2024)
Table 53. Global Gabapentin Enacarbil Sales Market Share by Type (2024-2034)
Table 54. Global Gabapentin Enacarbil Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Gabapentin Enacarbil Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Gabapentin Enacarbil Revenue Market Share by Type (2018-2024)
Table 57. Global Gabapentin Enacarbil Revenue Market Share by Type (2024-2034)
Table 58. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2018-2024)
Table 59. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2024-2034)
Table 60. Global Gabapentin Enacarbil Sales (K Units) by Application (2018-2024)
Table 61. Global Gabapentin Enacarbil Sales (K Units) by Application (2024-2034)
Table 62. Global Gabapentin Enacarbil Sales Market Share by Application (2018-2024)
Table 63. Global Gabapentin Enacarbil Sales Market Share by Application (2024-2034)
Table 64. Global Gabapentin Enacarbil Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Gabapentin Enacarbil Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Gabapentin Enacarbil Revenue Market Share by Application (2018-2024)
Table 67. Global Gabapentin Enacarbil Revenue Market Share by Application (2024-2034)
Table 68. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2018-2024)
Table 69. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2024-2034)
Table 70. Arbor Pharma Corporation Information
Table 71. Arbor Pharma Description and Business Overview
Table 72. Arbor Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Arbor Pharma Gabapentin Enacarbil Product
Table 74. Arbor Pharma Recent Developments/Updates
Table 75. Astellas Corporation Information
Table 76. Astellas Description and Business Overview
Table 77. Astellas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Astellas Gabapentin Enacarbil Product
Table 79. Astellas Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GlaxoSmithKline Gabapentin Enacarbil Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Glenmark Pharma Corporation Information
Table 86. Glenmark Pharma Description and Business Overview
Table 87. Glenmark Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Glenmark Pharma Gabapentin Enacarbil Product
Table 89. Glenmark Pharma Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Pfizer Gabapentin Enacarbil Product
Table 94. Pfizer Recent Developments/Updates
Table 95. Depomed Corporation Information
Table 96. Depomed Description and Business Overview
Table 97. Depomed Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Depomed Gabapentin Enacarbil Product
Table 99. Depomed Recent Developments/Updates
Table 100. Teva Corporation Information
Table 101. Teva Description and Business Overview
Table 102. Teva Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Teva Gabapentin Enacarbil Product
Table 104. Teva Recent Developments/Updates
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Mylan Gabapentin Enacarbil Product
Table 109. Mylan Recent Developments/Updates
Table 110. Novartis Corporation Information
Table 111. Novartis Description and Business Overview
Table 112. Novartis Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novartis Gabapentin Enacarbil Product
Table 114. Novartis Recent Developments/Updates
Table 115. Apotex Corporation Information
Table 116. Apotex Description and Business Overview
Table 117. Apotex Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Apotex Gabapentin Enacarbil Product
Table 119. Apotex Recent Developments/Updates
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sun Pharmaceutical Gabapentin Enacarbil Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Aurobindo Pharma Gabapentin Enacarbil Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Intas Corporation Information
Table 131. Intas Description and Business Overview
Table 132. Intas Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Intas Gabapentin Enacarbil Product
Table 134. Intas Recent Developments/Updates
Table 135. Amneal Corporation Information
Table 136. Amneal Description and Business Overview
Table 137. Amneal Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Amneal Gabapentin Enacarbil Product
Table 139. Amneal Recent Developments/Updates
Table 140. Marksans Pharma Corporation Information
Table 141. Marksans Pharma Description and Business Overview
Table 142. Marksans Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Marksans Pharma Gabapentin Enacarbil Product
Table 144. Marksans Pharma Recent Developments/Updates
Table 145. Alkem Corporation Information
Table 146. Alkem Description and Business Overview
Table 147. Alkem Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Alkem Gabapentin Enacarbil Product
Table 149. Alkem Recent Developments/Updates
Table 150. Jiangsu Enhua Corporation Information
Table 151. Jiangsu Enhua Description and Business Overview
Table 152. Jiangsu Enhua Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Jiangsu Enhua Gabapentin Enacarbil Product
Table 154. Jiangsu Enhua Recent Developments/Updates
Table 155. Jiangsu Hengrui Corporation Information
Table 156. Jiangsu Hengrui Description and Business Overview
Table 157. Jiangsu Hengrui Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Jiangsu Hengrui Gabapentin Enacarbil Product
Table 159. Jiangsu Hengrui Recent Developments/Updates
Table 160. Sailike Pharma Corporation Information
Table 161. Sailike Pharma Description and Business Overview
Table 162. Sailike Pharma Gabapentin Enacarbil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Sailike Pharma Gabapentin Enacarbil Product
Table 164. Sailike Pharma Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Gabapentin Enacarbil Distributors List
Table 168. Gabapentin Enacarbil Customers List
Table 169. Gabapentin Enacarbil Market Trends
Table 170. Gabapentin Enacarbil Market Drivers
Table 171. Gabapentin Enacarbil Market Challenges
Table 172. Gabapentin Enacarbil Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin Enacarbil
Figure 2. Global Gabapentin Enacarbil Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Gabapentin Enacarbil Market Share by Type in 2022 & 2034
Figure 4. Capsule Product Picture
Figure 5. Tablet Product Picture
Figure 6. Global Gabapentin Enacarbil Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Gabapentin Enacarbil Market Share by Application in 2022 & 2034
Figure 8. Post-Herpetic Neuralgia (PHN)
Figure 9. Restless Legs Syndrome (RLS)
Figure 10. Others
Figure 11. Global Gabapentin Enacarbil Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 12. Global Gabapentin Enacarbil Market Size (2018-2034) & (US$ Million)
Figure 13. Global Gabapentin Enacarbil Sales (2018-2034) & (K Units)
Figure 14. Global Gabapentin Enacarbil Average Price (US$/Unit) & (2018-2034)
Figure 15. Gabapentin Enacarbil Report Years Considered
Figure 16. Gabapentin Enacarbil Sales Share by Manufacturers in 2022
Figure 17. Global Gabapentin Enacarbil Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Gabapentin Enacarbil Players: Market Share by Revenue in 2022
Figure 19. Gabapentin Enacarbil Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Gabapentin Enacarbil Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 21. North America Gabapentin Enacarbil Sales Market Share by Country (2018-2034)
Figure 22. North America Gabapentin Enacarbil Revenue Market Share by Country (2018-2034)
Figure 23. United States Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Gabapentin Enacarbil Sales Market Share by Country (2018-2034)
Figure 26. Europe Gabapentin Enacarbil Revenue Market Share by Country (2018-2034)
Figure 27. Germany Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Gabapentin Enacarbil Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Gabapentin Enacarbil Revenue Market Share by Region (2018-2034)
Figure 34. China Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. China Taiwan Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Gabapentin Enacarbil Sales Market Share by Country (2018-2034)
Figure 44. Latin America Gabapentin Enacarbil Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Gabapentin Enacarbil Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Gabapentin Enacarbil Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Gabapentin Enacarbil Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Gabapentin Enacarbil by Type (2018-2034)
Figure 54. Global Revenue Market Share of Gabapentin Enacarbil by Type (2018-2034)
Figure 55. Global Gabapentin Enacarbil Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Gabapentin Enacarbil by Application (2018-2034)
Figure 57. Global Revenue Market Share of Gabapentin Enacarbil by Application (2018-2034)
Figure 58. Global Gabapentin Enacarbil Price (US$/Unit) by Application (2018-2034)
Figure 59. Gabapentin Enacarbil Value Chain
Figure 60. Gabapentin Enacarbil Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed